Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Assessment of climate change effects on mountain ecosystems through a cross-site analysis in the Alps and Apennines.

Rogora M, Frate L, Carranza ML, Freppaz M, Stanisci A, Bertani I, Bottarin R, Brambilla A, Canullo R, Carbognani M, Cerrato C, Chelli S, Cremonese E, Cutini M, Di Musciano M, Erschbamer B, Godone D, Iocchi M, Isabellon M, Magnani A, Mazzola L, Morra di Cella U, Pauli H, Petey M, Petriccione B, Porro F, Psenner R, Rossetti G, Scotti A, Sommaruga R, Tappeiner U, Theurillat JP, Tomaselli M, Viglietti D, Viterbi R, Vittoz P, Winkler M, Matteucci G.

Sci Total Environ. 2018 May 15;624:1429-1442. doi: 10.1016/j.scitotenv.2017.12.155. Epub 2017 Dec 27.

PMID:
29929254
2.

Accelerated increase in plant species richness on mountain summits is linked to warming.

Steinbauer MJ, Grytnes JA, Jurasinski G, Kulonen A, Lenoir J, Pauli H, Rixen C, Winkler M, Bardy-Durchhalter M, Barni E, Bjorkman AD, Breiner FT, Burg S, Czortek P, Dawes MA, Delimat A, Dullinger S, Erschbamer B, Felde VA, Fernández-Arberas O, Fossheim KF, Gómez-García D, Georges D, Grindrud ET, Haider S, Haugum SV, Henriksen H, Herreros MJ, Jaroszewicz B, Jaroszynska F, Kanka R, Kapfer J, Klanderud K, Kühn I, Lamprecht A, Matteodo M, di Cella UM, Normand S, Odland A, Olsen SL, Palacio S, Petey M, Piscová V, Sedlakova B, Steinbauer K, Stöckli V, Svenning JC, Teppa G, Theurillat JP, Vittoz P, Woodin SJ, Zimmermann NE, Wipf S.

Nature. 2018 Apr;556(7700):231-234. doi: 10.1038/s41586-018-0005-6. Epub 2018 Apr 4.

PMID:
29618821
3.

Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.

Janouskova H, El Tekle G, Bellini E, Udeshi ND, Rinaldi A, Ulbricht A, Bernasocchi T, Civenni G, Losa M, Svinkina T, Bielski CM, Kryukov GV, Cascione L, Napoli S, Enchev RI, Mutch DG, Carney ME, Berchuck A, Winterhoff BJN, Broaddus RR, Schraml P, Moch H, Bertoni F, Catapano CV, Peter M, Carr SA, Garraway LA, Wild PJ, Theurillat JP.

Nat Med. 2017 Sep;23(9):1046-1054. doi: 10.1038/nm.4372. Epub 2017 Aug 14.

4.

Targeting transcriptional co-activators in advanced prostate cancer.

Groner AC, Brown M, Theurillat JP.

Cell Cycle. 2016 Dec 16;15(24):3333-3334. doi: 10.1080/15384101.2016.1229019. Epub 2016 Sep 9. No abstract available.

5.

Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.

Gomes AL, Teijeiro A, Burén S, Tummala KS, Yilmaz M, Waisman A, Theurillat JP, Perna C, Djouder N.

Cancer Cell. 2016 Jul 11;30(1):161-175. doi: 10.1016/j.ccell.2016.05.020.

6.

TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Groner AC, Cato L, de Tribolet-Hardy J, Bernasocchi T, Janouskova H, Melchers D, Houtman R, Cato ACB, Tschopp P, Gu L, Corsinotti A, Zhong Q, Fankhauser C, Fritz C, Poyet C, Wagner U, Guo T, Aebersold R, Garraway LA, Wild PJ, Theurillat JP, Brown M.

Cancer Cell. 2016 Jun 13;29(6):846-858. doi: 10.1016/j.ccell.2016.04.012. Epub 2016 May 26.

7.

Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas.

Jennewein L, Ronellenfitsch MW, Antonietti P, Ilina EI, Jung J, Stadel D, Flohr LM, Zinke J, von Renesse J, Drott U, Baumgarten P, Braczynski AK, Penski C, Burger MC, Theurillat JP, Steinbach JP, Plate KH, Dikic I, Fulda S, Brandts C, Kögel D, Behrends C, Harter PN, Mittelbronn M.

Oncotarget. 2016 Apr 12;7(15):20016-32. doi: 10.18632/oncotarget.7910.

8.

Testate Amoebae Like It Hot: Species Richness Decreases Along a Subalpine-Alpine Altitudinal Gradient in Both Natural Calluna vulgaris Litter and Transplanted Minuartia sedoides Cushions.

Heger TJ, Derungs N, Theurillat JP, Mitchell EA.

Microb Ecol. 2016 Apr;71(3):725-34. doi: 10.1007/s00248-015-0687-3. Epub 2015 Oct 20.

PMID:
26487438
9.

Tree cover at fine and coarse spatial grains interacts with shade tolerance to shape plant species distributions across the Alps.

Nieto-Lugilde D, Lenoir J, Abdulhak S, Aeschimann D, Dullinger S, Gégout JC, Guisan A, Pauli H, Renaud J, Theurillat JP, Thuiller W, Van Es J, Vittoz P, Willner W, Wohlgemuth T, Zimmermann NE, Svenning JC.

Ecography (Cop.). 2015 Jun 1;38(6):578-589.

10.

Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Theurillat JP, Udeshi ND, Errington WJ, Svinkina T, Baca SC, Pop M, Wild PJ, Blattner M, Groner AC, Rubin MA, Moch H, Prive GG, Carr SA, Garraway LA.

Science. 2014 Oct 3;346(6205):85-89. doi: 10.1126/science.1250255. Epub 2014 Oct 2.

11.

A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.

Pop MS, Stransky N, Garvie CW, Theurillat JP, Hartman EC, Lewis TA, Zhong C, Culyba EK, Lin F, Daniels DS, Pagliarini R, Ronco L, Koehler AN, Garraway LA.

Mol Cancer Ther. 2014 Jun;13(6):1492-502. doi: 10.1158/1535-7163.MCT-13-0689. Epub 2014 Apr 15.

12.

Punctuated evolution of prostate cancer genomes.

Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, Park K, Kitabayashi N, MacDonald TY, Ghandi M, Van Allen E, Kryukov GV, Sboner A, Theurillat JP, Soong TD, Nickerson E, Auclair D, Tewari A, Beltran H, Onofrio RC, Boysen G, Guiducci C, Barbieri CE, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Ramos AH, Winckler W, Cipicchio M, Ardlie K, Kantoff PW, Berger MF, Gabriel SB, Golub TR, Meyerson M, Lander ES, Elemento O, Getz G, Demichelis F, Rubin MA, Garraway LA.

Cell. 2013 Apr 25;153(3):666-77. doi: 10.1016/j.cell.2013.03.021.

13.

A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.

Whittaker SR, Theurillat JP, Van Allen E, Wagle N, Hsiao J, Cowley GS, Schadendorf D, Root DE, Garraway LA.

Cancer Discov. 2013 Mar;3(3):350-62. doi: 10.1158/2159-8290.CD-12-0470. Epub 2013 Jan 3.

14.

A landscape of driver mutations in melanoma.

Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L.

Cell. 2012 Jul 20;150(2):251-63. doi: 10.1016/j.cell.2012.06.024.

15.

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio RC, Park K, Kitabayashi N, MacDonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, Ardlie K, Tewari AK, Mosquera JM, Rupp N, Wild PJ, Moch H, Morrissey C, Nelson PS, Kantoff PW, Gabriel SB, Golub TR, Meyerson M, Lander ES, Getz G, Rubin MA, Garraway LA.

Nat Genet. 2012 May 20;44(6):685-9. doi: 10.1038/ng.2279.

16.

Recent plant diversity changes on Europe's mountain summits.

Pauli H, Gottfried M, Dullinger S, Abdaladze O, Akhalkatsi M, Benito Alonso JL, Coldea G, Dick J, Erschbamer B, Fernández Calzado R, Ghosn D, Holten JI, Kanka R, Kazakis G, Kollár J, Larsson P, Moiseev P, Moiseev D, Molau U, Molero Mesa J, Nagy L, Pelino G, Puşcaş M, Rossi G, Stanisci A, Syverhuset AO, Theurillat JP, Tomaselli M, Unterluggauer P, Villar L, Vittoz P, Grabherr G.

Science. 2012 Apr 20;336(6079):353-5. doi: 10.1126/science.1219033.

17.

URI is an oncogene amplified in ovarian cancer cells and is required for their survival.

Theurillat JP, Metzler SC, Henzi N, Djouder N, Helbling M, Zimmermann AK, Jacob F, Soltermann A, Caduff R, Heinzelmann-Schwarz V, Moch H, Krek W.

Cancer Cell. 2011 Mar 8;19(3):317-32. doi: 10.1016/j.ccr.2011.01.019.

18.

Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.

Gorr TA, Wichmann D, Pilarsky C, Theurillat JP, Fabrizius A, Laufs T, Bauer T, Koslowski M, Horn S, Burmester T, Hankeln T, Kristiansen G.

Acta Physiol (Oxf). 2011 Jul;202(3):563-81. doi: 10.1111/j.1748-1716.2010.02205.x. Epub 2010 Nov 12.

PMID:
20958924
19.

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.

Kristiansen G, Rose M, Geisler C, Fritzsche FR, Gerhardt J, Lüke C, Ladhoff AM, Knüchel R, Dietel M, Moch H, Varga Z, Theurillat JP, Gorr TA, Dahl E.

Br J Cancer. 2010 Jun 8;102(12):1736-45. doi: 10.1038/sj.bjc.6605702.

20.

Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer.

Theurillat JP, Dreier B, Nagy-Davidescu G, Seifert B, Behnke S, Zürrer-Härdi U, Ingold F, Plückthun A, Moch H.

Mod Pathol. 2010 Sep;23(9):1289-97. doi: 10.1038/modpathol.2010.103. Epub 2010 May 21.

21.

IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity.

Probst-Hensch NM, Steiner JH, Schraml P, Varga Z, Zürrer-Härdi U, Storz M, Korol D, Fehr MK, Fink D, Pestalozzi BC, Lütolf UM, Theurillat JP, Moch H.

Clin Cancer Res. 2010 Feb 1;16(3):1025-32. doi: 10.1158/1078-0432.CCR-09-0957. Epub 2010 Jan 26.

22.

A role for NBR1 in autophagosomal degradation of ubiquitinated substrates.

Kirkin V, Lamark T, Sou YS, Bjørkøy G, Nunn JL, Bruun JA, Shvets E, McEwan DG, Clausen TH, Wild P, Bilusic I, Theurillat JP, Øvervatn A, Ishii T, Elazar Z, Komatsu M, Dikic I, Johansen T.

Mol Cell. 2009 Feb 27;33(4):505-16. doi: 10.1016/j.molcel.2009.01.020.

23.

Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.

Theurillat JP, Zürrer-Härdi U, Varga Z, Barghorn A, Saller E, Frei C, Storz M, Behnke S, Seifert B, Fehr M, Fink D, Rageth C, Linsenmeier C, Pestalozzi B, Chen YT, Knuth A, Jäger D, Moch H.

Int J Cancer. 2008 Apr 1;122(7):1585-91.

24.

NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.

Theurillat JP, Zürrer-Härdi U, Varga Z, Storz M, Probst-Hensch NM, Seifert B, Fehr MK, Fink D, Ferrone S, Pestalozzi B, Jungbluth AA, Chen YT, Jäger D, Knuth A, Moch H.

Cancer Immunol Immunother. 2007 Nov;56(11):1723-31. Epub 2007 Apr 5.

PMID:
17410359
25.

NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration.

Theurillat JP, Ingold F, Frei C, Zippelius A, Varga Z, Seifert B, Chen YT, Jäger D, Knuth A, Moch H.

Int J Cancer. 2007 Jun 1;120(11):2411-7.

26.

Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.

Varga Z, Theurillat JP, Filonenko V, Sasse B, Odermatt B, Jungbluth AA, Chen YT, Old LJ, Knuth A, Jäger D, Moch H.

Clin Cancer Res. 2006 May 1;12(9):2745-51.

27.

Morphologic changes and altered gene expression in an epithelioid hemangioendothelioma during a ten-year course of disease.

Theurillat JP, Vavricka SR, Went P, Weishaupt D, Perren A, Leonard-Meier C, Bachli EB.

Pathol Res Pract. 2003;199(3):165-70.

PMID:
12812318
28.

Aluminum in the opal silica reticule of phytoliths: a new tool in palaeoecological studies.

Carnelli AL, Madella M, Theurillat JP, Ammann B.

Am J Bot. 2002 Feb;89(2):346-51. doi: 10.3732/ajb.89.2.346.

29.

Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.

Theurillat JP, Hainfellner J, Maddalena A, Weissenberger J, Aguzzi A.

Am J Pathol. 1999 Feb;154(2):581-90.

Supplemental Content

Loading ...
Support Center